PeptideDB

Citrusin B

CAS No.: 105279-10-5

Citrusin B exhibits moderate in vitro inhibitory effect on tobacco mosaic virus replication withIC50 values 0.26 mmol 
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Citrusin B exhibits moderate in vitro inhibitory effect on tobacco mosaic virus replication with IC50 values 0.26 mmol L⁻1.
In vitro METHODS AND RESULTS: A new seco-neolignan glycoside, seco-dehydrodiconiferyl alcohol-4-O-β-D-glucopyranoside, together with eight known compounds, were obtained from the EtOH extract of the root bark of Ailanthus altissima. Their structures were elucidated based on the spectroscopic data. CONCLUSIONS: Three neolignan glycosides including 7,9,9'-trihydroxy-3,3',5'-trimethoxy-8-O-4'-neolignan-4-O-β-D-glucopyranoside, sonchifolignan B and Citrusin B exhibited moderate in vitro inhibitory effect on tobacco mosaic virus replication with IC50 values 0.30, 0.35 and 0.26?mmol?L?1, respectively.
molecular weight 568.572
Molecular formula C27H36O13
CAS 105279-10-5
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. A new seco-neolignan glycoside from the root bark of Ailanthus altissima. Nat Prod Res. 2012;26(15):1375-80.